Dias, A. L., & Jain, D. (2013). Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia by Bruton’s Tyrosine Kinase Inhibition. Bentham Science Publishers.
Chicago ZitierstilDias, Ajoy Lawrence, und Dharamvir Jain. Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia By Bruton’s Tyrosine Kinase Inhibition. Bentham Science Publishers, 2013.
MLA ZitierstilDias, Ajoy Lawrence, und Dharamvir Jain. Ibrutinib: A New Frontier in the Treatment of Chronic Lymphocytic Leukemia By Bruton’s Tyrosine Kinase Inhibition. Bentham Science Publishers, 2013.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.